Fundamental dimension Equity attribute | BIOLeader $369.95▲+1.77% Cap $9.89BP/E 44.4x QuantScore53/100 | AZTAPeer $36.50▲+1.36% Cap $1.60BP/E -13.3x QuantScore51/100 | BRKRPeer $57.59▲+0.49% Cap $8.77BP/E -82.4x QuantScore33/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
84/100 |
71/100 |
54/100 |
Valuation Multiples, PEG & DCF upside | 40/100 | 25/100 | 19/100 |
Health Piotroski, Altman Z, leverage & liquidity | 70/100 | 71/100 | 41/100 |
Growth Revenue / earnings growth & margins | 35/100 | 37/100 | 23/100 |
Sentiment Analyst ratings, targets & revisions | 35/100 | 51/100 | 28/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 44.4x | -13.3x | -82.4x |
Forward P/E (next FY) | 37.9x | 114.8x | 27.1x |
EV / EBITDA (TTM) | 20.6x | -15.1x | 42.4x |
Price / Sales | 3.8x | 2.6x | 2.5x |
Price / Free Cash Flow | 28.0x | 161.8x | 93.4x |
PEG ratio | -0.15 | 0.05 | 0.94 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 4 / 9 | 5 / 9 |
Altman Z-Score | 3.64 (Safe) | 3.87 (Safe) | 2.76 (Grey) |
Total debt / equity | 0.17 | 0.04 | 0.80 |
Quick ratio | 2.3x | 2.2x | 0.9x |
Interest coverage | 6.4x | — | 2.9x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +0.7% | +3.6% | +2.1% |
Net income growth YoY | +141.2% | +66.2% | -107.6% |
Gross margin (TTM) | 51.9% | 44.0% | 46.7% |
Operating margin (FY) | 10.5% | -1.9% | 6.9% |
FCF margin (FY) | 14.5% | 6.5% | 0.4% |
5. Trailing price performancePrice change over period |
1M return | -4.5% | +6.7% | -10.0% |
3M return | +17.6% | +33.4% | -4.7% |
6M return | +28.5% | +40.9% | +57.6% |
Year to date | +22.1% | +9.7% | +22.2% |
1Y return | +8.9% | +13.1% | +47.7% |
3Y return | +21.8% | -27.7% | -2.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-169.71 -145.9% premium | $10.55 -71.1% premium | $34.55 -40.0% premium |
Wall Street consensus target | $350.00 -5.4% · range $310.00–$390.00 | $43.00 +17.8% · range $38.00–$45.00 | $67.00 +16.3% · range $50.00–$80.00 |
Consensus stance | 57% Buy43% Hold0% Sell | 58% Buy42% Hold-0% Sell | 48% Buy45% Hold6% Sell |